BioNTech is a biotechnology company based in Germany, known for its pioneering work in the field of mRNA technology for medical applications. The company gained worldwide recognition for developing one of the first COVID-19 vaccines, in collaboration with Pfizer, utilizing messenger RNA (mRNA) to stimulate an immune response against the virus. Founded in 2008, BioNTech focuses on developing innovative therapies for cancer and other serious diseases, leveraging its proprietary mRNA platform to create personalized treatments and vaccines. The company emphasizes a patient-centric approach, aiming to improve outcomes through advanced biotechnology solutions.
BioNTech, known for its COVID-19 vaccine, is transitioning toward cancer therapy development. Fourth-quarter 2024 earnings fell to €1.08 per share but surpassed market expectations despite declining revenue. Annual results show…